» Articles » PMID: 15057312

Calcineurin is Required in Urinary Tract Mesenchyme for the Development of the Pyeloureteral Peristaltic Machinery

Overview
Journal J Clin Invest
Specialty General Medicine
Date 2004 Apr 2
PMID 15057312
Citations 68
Authors
Affiliations
Soon will be listed here.
Abstract

Congenital obstructive nephropathy is the principal cause of renal failure in infants and children. The underlying molecular and cellular mechanisms of this disease, however, remain largely undetermined. We generated a mouse model of congenital obstructive nephropathy that resembles ureteropelvic junction obstruction in humans. In these mice, calcineurin function is removed by the selective deletion of Cnb1 in the mesenchyme of the developing urinary tract using the Cre/lox system. This deletion results in reduced proliferation in the smooth muscle cells and other mesenchymal cells in the developing urinary tract. Compromised cell proliferation causes abnormal development of the renal pelvis and ureter, leading to defective pyeloureteral peristalsis, progressive renal obstruction, and, eventually, fatal renal failure. Our study demonstrates that calcineurin is an essential signaling molecule in urinary tract development and is required for normal proliferation of the urinary tract mesenchymal cells in a cell-autonomous manner. These studies also emphasize the importance of functional obstruction, resulting from developmental abnormality, in causing congenital obstructive nephropathy.

Citing Articles

Pyeloureteral Junction Syndrome in a Neonate With a Solitary Kidney Treated by Anderson-Hynes Pyeloplasty: A Case Report.

Benomar I, Qarouach S, Rami M, Belkacem R, Bouhafs M Cureus. 2024; 16(7):e65589.

PMID: 39192924 PMC: 11349144. DOI: 10.7759/cureus.65589.


Pelvico-Vesicostomy for Horseshoe Kidney With Severe Right Ureteric Stricture and Bilateral Hydronephrosis.

Devasilpa Raju P, Khedkar K, Lamture Y Cureus. 2023; 14(12):e32938.

PMID: 36712721 PMC: 9873531. DOI: 10.7759/cureus.32938.


Embryology and Morphological (Mal)Development of UPJ.

Avanoglu A, Tiryaki S Front Pediatr. 2020; 8:137.

PMID: 32318525 PMC: 7154125. DOI: 10.3389/fped.2020.00137.


DTI of the kidney in children: comparison between normal kidneys and those with ureteropelvic junction (UPJ) obstruction.

Otero H, Calle-Toro J, Maya C, Darge K, Serai S MAGMA. 2019; 33(1):63-71.

PMID: 31845301 DOI: 10.1007/s10334-019-00812-9.


Histology Atlas of the Developing Mouse Urinary System With Emphasis on Prenatal Days E10.5-E18.5.

Elmore S, Kavari S, Hoenerhoff M, Mahler B, Scott B, Yabe K Toxicol Pathol. 2019; 47(7):865-886.

PMID: 31599209 PMC: 6814567. DOI: 10.1177/0192623319873871.


References
1.
Clipstone N, Crabtree G . Calcineurin is a key signaling enzyme in T lymphocyte activation and the target of the immunosuppressive drugs cyclosporin A and FK506. Ann N Y Acad Sci. 1993; 696:20-30. DOI: 10.1111/j.1749-6632.1993.tb17138.x. View

2.
Chang C, Chen L, Crabtree G . Sonographic staging of the developmental status of mouse embryos in utero. Genesis. 2003; 36(1):7-11. DOI: 10.1002/gene.10186. View

3.
Dibona G, Kopp U . Neural control of renal function. Physiol Rev. 1997; 77(1):75-197. DOI: 10.1152/physrev.1997.77.1.75. View

4.
Tumlin J, Lea J, Swanson C, Smith C, Edge S, Someren J . Aldosterone and dexamethasone stimulate calcineurin activity through a transcription-independent mechanism involving steroid receptor-associated heat shock proteins. J Clin Invest. 1997; 99(6):1217-23. PMC: 507935. DOI: 10.1172/JCI119278. View

5.
Winder D, Mansuy I, Osman M, Moallem T, Kandel E . Genetic and pharmacological evidence for a novel, intermediate phase of long-term potentiation suppressed by calcineurin. Cell. 1998; 92(1):25-37. DOI: 10.1016/s0092-8674(00)80896-x. View